517 related articles for article (PubMed ID: 36139142)
21. CD33-Specific Chimeric Antigen Receptor T Cells with Different Co-Stimulators Showed Potent Anti-Leukemia Efficacy and Different Phenotype.
Li S; Tao Z; Xu Y; Liu J; An N; Wang Y; Xing H; Tian Z; Tang K; Liao X; Rao Q; Wang M; Wang J
Hum Gene Ther; 2018 May; 29(5):626-639. PubMed ID: 29409351
[TBL] [Abstract][Full Text] [Related]
22. CD27 agonism coordinates with CD28 and 4-1BB signal to augment the efficacy of CAR-T cells in colorectal tumor.
Zhang C; Jia J; Heng G; Li Y; Wang M; Chen J; Wang L; Jiang D; Yang Z; Qian C
Med Oncol; 2023 Mar; 40(4):123. PubMed ID: 36944898
[TBL] [Abstract][Full Text] [Related]
23. Distinct functions of CAR-T cells possessing a dectin-1 intracellular signaling domain.
Liang X; Huang Y; Li D; Yang X; Jiang L; Zhou W; Su J; Chen N; Wang W
Gene Ther; 2023 May; 30(5):411-420. PubMed ID: 33953316
[TBL] [Abstract][Full Text] [Related]
24. A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq.
Boroughs AC; Larson RC; Marjanovic ND; Gosik K; Castano AP; Porter CBM; Lorrey SJ; Ashenberg O; Jerby L; Hofree M; Smith-Rosario G; Morris R; Gould J; Riley LS; Berger TR; Riesenfeld SJ; Rozenblatt-Rosen O; Choi BD; Regev A; Maus MV
Mol Ther; 2020 Dec; 28(12):2577-2592. PubMed ID: 32755564
[TBL] [Abstract][Full Text] [Related]
25. Chimeric antigen receptor T-cells: Properties, production, and quality control.
Ramesh P; Hui HYL; Brownrigg LM; Fuller KA; Erber WN
Int J Lab Hematol; 2023 Aug; 45(4):425-435. PubMed ID: 37337970
[TBL] [Abstract][Full Text] [Related]
26. Design and Assessment of Novel Anti-CD30 Chimeric Antigen Receptors with Human Antigen-Recognition Domains.
Choi S; Pegues MA; Lam N; Geldres C; Vanasse D; Kochenderfer JN
Hum Gene Ther; 2021 Jul; 32(13-14):730-743. PubMed ID: 33287637
[TBL] [Abstract][Full Text] [Related]
27. Road testing new CAR design strategies in multiple myeloma.
Rana PS; Murphy EV; Kort J; Driscoll JJ
Front Immunol; 2022; 13():957157. PubMed ID: 36016950
[TBL] [Abstract][Full Text] [Related]
28. Herpes Virus Entry Mediator Costimulation Signaling Enhances CAR T-cell Efficacy Against Solid Tumors Through Metabolic Reprogramming.
Sun S; Huang C; Lu M; Xu H; Yuan Y; Zhao W; Hu X; Wang B; Zhang W; Gao X; Zheng J; Su L; Zhang Q
Cancer Immunol Res; 2023 Apr; 11(4):515-529. PubMed ID: 36689620
[TBL] [Abstract][Full Text] [Related]
29. Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors.
Hirabayashi K; Du H; Xu Y; Shou P; Zhou X; Fucá G; Landoni E; Sun C; Chen Y; Savoldo B; Dotti G
Nat Cancer; 2021 Sep; 2(9):904-918. PubMed ID: 34746799
[TBL] [Abstract][Full Text] [Related]
30. Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy.
Olguín-Contreras LF; Mendler AN; Popowicz G; Hu B; Noessner E
Front Immunol; 2021; 12():750478. PubMed ID: 34912334
[TBL] [Abstract][Full Text] [Related]
31. Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells.
Singh N; Frey NV; Engels B; Barrett DM; Shestova O; Ravikumar P; Cummins KD; Lee YG; Pajarillo R; Chun I; Shyu A; Highfill SL; Price A; Zhao L; Peng L; Granda B; Ramones M; Lu XM; Christian DA; Perazzelli J; Lacey SF; Roy NH; Burkhardt JK; Colomb F; Damra M; Abdel-Mohsen M; Liu T; Liu D; Standley DM; Young RM; Brogdon JL; Grupp SA; June CH; Maude SL; Gill S; Ruella M
Nat Med; 2021 May; 27(5):842-850. PubMed ID: 33888899
[TBL] [Abstract][Full Text] [Related]
32. PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
Jie Y; Liu G; Feng L; Li Y; E M; Wu L; Li Y; Rong G; Li Y; Wei H; Gu A
Front Immunol; 2021; 12():665970. PubMed ID: 34475869
[TBL] [Abstract][Full Text] [Related]
33. Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2
Priceman SJ; Tilakawardane D; Jeang B; Aguilar B; Murad JP; Park AK; Chang WC; Ostberg JR; Neman J; Jandial R; Portnow J; Forman SJ; Brown CE
Clin Cancer Res; 2018 Jan; 24(1):95-105. PubMed ID: 29061641
[No Abstract] [Full Text] [Related]
34. The signaling and the metabolic differences of various CAR T cell designs.
Razavi AS; Loskog A; Razi S; Rezaei N
Int Immunopharmacol; 2023 Jan; 114():109593. PubMed ID: 36700773
[TBL] [Abstract][Full Text] [Related]
35. [Gene-modified T-cell therapy using chimeric antigen receptors for pediatric hematologic malignancies].
Nakazawa Y
Rinsho Ketsueki; 2016 Jun; 57(6):701-8. PubMed ID: 27384848
[TBL] [Abstract][Full Text] [Related]
36. ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype.
Moreno-Cortes E; Franco-Fuquen P; Garcia-Robledo JE; Forero J; Booth N; Castro JE
Front Oncol; 2023; 13():1200914. PubMed ID: 37719008
[TBL] [Abstract][Full Text] [Related]
37. Modification of Hinge/Transmembrane and Signal Transduction Domains Improves the Expression and Signaling Threshold of GXMR-CAR Specific to
Dos Santos MH; Machado MP; Kumaresan PR; da Silva TA
Cells; 2022 Oct; 11(21):. PubMed ID: 36359781
[TBL] [Abstract][Full Text] [Related]
38. Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer.
Priceman SJ; Gerdts EA; Tilakawardane D; Kennewick KT; Murad JP; Park AK; Jeang B; Yamaguchi Y; Yang X; Urak R; Weng L; Chang WC; Wright S; Pal S; Reiter RE; Wu AM; Brown CE; Forman SJ
Oncoimmunology; 2018; 7(2):e1380764. PubMed ID: 29308300
[TBL] [Abstract][Full Text] [Related]
39. PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.
Bishop DC; Xu N; Tse B; O'Brien TA; Gottlieb DJ; Dolnikov A; Micklethwaite KP
Mol Ther; 2018 Aug; 26(8):1883-1895. PubMed ID: 29861327
[TBL] [Abstract][Full Text] [Related]
40. Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.
Li W; Guo L; Rathi P; Marinova E; Gao X; Wu MF; Liu H; Dotti G; Gottschalk S; Metelitsa LS; Heczey A
Hum Gene Ther; 2017 May; 28(5):437-448. PubMed ID: 27530312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
